Klatka Janusz, Grywalska Ewelina, Hymos Anna, Krasowska Ewelina, Mielnik Michał, Siwicka-Gieroba Dorota, Markowicz Justyna, Trojanowski Piotr, Olszański Witold, Roliński Jacek
Department of Otolaryngology and Laryngeal Oncology, Medical University of Lublin, Lublin, Poland.
Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland.
Cent Eur J Immunol. 2017;42(3):252-258. doi: 10.5114/ceji.2017.70967. Epub 2017 Oct 30.
Tumours connected with head and neck comprise about 5% of all tumours. The most frequent histological type of laryngeal carcinoma is squamous cell carcinoma. Different research projects suggest that the role of T lymphocytes might be significant in tumour development. iNKT cells are a new subpopulation of T cells and show cytotoxic activity against tumours. iNKT cells participate in modulating the function of other cells which have anti-tumour properties and secrete cytokines, which have pro-inflammatory and anti-inflammatory effects. In animal models the significance of iNKT cells in various diseases including cancer was shown.
The aim of this study was to determine the percentages of iNKT cells, CD161+ cells, CD161- cells, iNKT CD4+ cells, and iNKT CD8+ cells, NK cells, NKT-like cells, and T cells subsets present in peripheral blood of patients with laryngeal cancer before and two months after the tumour resection, in comparison to healthy volunteers.
This study included material from laryngeal patients who were treated at the Department of Otolaryngology and Laryngological Oncology (Medical University of Lublin) between 2012 and 2013. A total of 50 patients (40 men and 10 women) aged between 45 and 77 years (median age: 60 years) were enrolled. Based on the TNM classification, the patients were classified as having stage I-IV laryngeal cancer. The control group was composed of 15 healthy volunteers (12 men and three women) aged between 43 and 82 years (median age: 61 years). The protocol of the study was approved by the Local Bioethical Committee at the Medical University of Lublin.Peripheral blood samples (15 ml) from the basilic vein were collected by venipuncture using sterile, sodium heparin-treated tubes (20 units per ml of blood) and used for cytometric analyses.
iNKT cells were analysed among T CD3+ cells. The percentage of CD3+ and CD3+CD4+ T cells before tumour resection was higher than in the control group, but the increase of CD3+ T cells was not significant. The T CD3+CD4+ / T CD3+CD8+ cell ratio was significantly higher than in healthy donors. After tumour resection a decreased percentage of CD3+CD4+ T cells but an increased percentage of CD8+CD3+T cells was noted. The T CD3+CD4+ / T CD3+CD8+ cell ratio was significantly higher in patients before and after the surgery than in the control group. The amount of NKT-like cells increased after resection and was significantly higher than in the control group.
Our study exhibited the change in percentage of iNKT, NK, NKT-like cells, and T lymphocytes after tumour resection in patients with laryngeal cancer. The research explains the contribution of those cells in immunological response against tumour.
头颈部肿瘤约占所有肿瘤的5%。喉癌最常见的组织学类型是鳞状细胞癌。不同的研究项目表明,T淋巴细胞在肿瘤发展中可能起重要作用。iNKT细胞是T细胞的一个新亚群,对肿瘤具有细胞毒性活性。iNKT细胞参与调节其他具有抗肿瘤特性的细胞的功能,并分泌具有促炎和抗炎作用的细胞因子。在动物模型中,iNKT细胞在包括癌症在内的各种疾病中的重要性已得到证实。
本研究的目的是确定喉癌患者肿瘤切除前和切除后两个月外周血中iNKT细胞、CD161+细胞、CD161-细胞、iNKT CD4+细胞、iNKT CD8+细胞、NK细胞、NKT样细胞和T细胞亚群的百分比,并与健康志愿者进行比较。
本研究纳入了2012年至2013年在卢布林医科大学耳鼻喉科和喉肿瘤学系接受治疗的喉癌患者的材料。共纳入50例患者(40例男性和10例女性),年龄在45至77岁之间(中位年龄:60岁)。根据TNM分类,患者被分类为I-IV期喉癌。对照组由15名健康志愿者(12名男性和3名女性)组成,年龄在43至82岁之间(中位年龄:61岁)。该研究方案经卢布林医科大学当地生物伦理委员会批准。通过静脉穿刺,使用无菌的、经肝素钠处理的试管(每毫升血液20单位)从贵要静脉采集15毫升外周血样本,用于细胞计数分析。
在T CD3+细胞中分析iNKT细胞。肿瘤切除前CD3+和CD3+CD4+ T细胞的百分比高于对照组,但CD3+ T细胞的增加不显著。T CD3+CD4+ / T CD3+CD8+细胞比值显著高于健康供体。肿瘤切除后,CD3+CD4+ T细胞百分比下降,但CD8+CD3+T细胞百分比增加。手术前后患者的T CD3+CD4+ / T CD3+CD8+细胞比值均显著高于对照组。切除后NKT样细胞数量增加,且显著高于对照组。
我们的研究显示了喉癌患者肿瘤切除后iNKT、NK、NKT样细胞和T淋巴细胞百分比的变化。该研究解释了这些细胞在抗肿瘤免疫反应中的作用。